Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy
- 1 February 2010
- journal article
- research article
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 22 (2) , 199-206
Abstract
Background Hepatic encephalopathy (HE) is a reversible neuropsychiatric syndrome in patients with liver disease. It was suggested that Bifidobacterium+fructo-oligosaccharides (FOS) may decrease blood and brain ammonia levels. Aim The study was conducted to compare the efficacy of Bifidobacterium+FOS and lactulose in patients with HE. Methods One hundred and twenty-five patients (35 hepatitis B virus infected, 70 hepatitis C virus infected and 20 cryptogenetic cirrhosis) were enrolled in the study. Patients were randomized either to a treatment for 60 days with Bifidobacterium and FOS (group A) or into-group receiving lactulose (group B) in double-blind. Results After 30 days of the study period, the Bifidobacterium+FOS-treated patients compared with lactulose-treated patients showed a significant decrease of Trail Making Test B (TMT B) (PPP4 fasting HE1 (PPPPP<0.001). Conclusion The treatment with Bifidobacterium+FOS is an alternative to the use of lactulose in patients with cirrhosis, for its usefulness in reducing blood ammonia levels and improvement of psychometric tests.Keywords
This publication has 30 references indexed in Scilit:
- Intestinal glutaminase activity is increased in liver cirrhosis and correlates with minimal hepatic encephalopathyJournal of Hepatology, 2004
- The Kidney Plays A Major Role in the Hyperammonemia Seen After Simulated or Actual Gi Bleeding in Patients With CirrhosisHepatology, 2003
- Bradykinesia in minimal hepatic encephalopathy is due to disturbances in movement initiationJournal of Hepatology, 2003
- Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998Hepatology, 2002
- Hepatic encephalopathyAmerican Journal of Gastroenterology, 2001
- Focal Neurological Signs in Hepatic Encephalopathy in Cirrhotic Patients: An Underestimated Entity?American Journal of Gastroenterology, 2001
- Diagnosis of EncephalopathyDigestion, 1998
- A Clinical Hepatologist's Predictions about Non-Absorbed Carbohydrates for the Early Twenty-First CenturyScandinavian Journal of Gastroenterology, 1997
- Gaseous response to ingestion of a poorly absorbed fructo-oligosaccharide sweetenerThe American Journal of Clinical Nutrition, 1987
- Ammonia: Key factor in the pathogenesis of hepatic encephalopathyNeurochemical Pathology, 1987